Editorial Review Novel anti-inflammatory drugs in hypertension

‘Atherosclerosis is a chronic inflammatory disease induced by cholesterol...’ Rudolf Virchow (1821–1902) As suggested by Virchow more than a century ago, inflammation plays a pivotal role in atherogenesis and potentially also in the pathogenesis of hypertension and its sequelae. As such, the current review focuses on the role of inflammation in hypertension and emerging therapeutical approaches. Inflammation and cardiovascular risk Clinical data Over the last years chronic low-grade inflammation has emerged as an important new cardiovascular risk factor. Inflammatory responses within the vasculature might release pro-inflammatory cytokines that increas